Vimarsana
Biggest News Aggregation in the World

Page 3 - Confidence Interval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Confidence Interval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Confidence Interval Today - Breaking & Trending Today

CSIR NET Life Science Syllabus 2024, Download Syllabus PDF - Vimarsana News

CSIR NET Life Science Syllabus 2024, Download Syllabus PDF

CSIR NET Life Science Syllabus: Check detailed unit-wise CSIR NET Life Science syllabus for Parts A, B and C along with exam pattern and preparation tips. Download CSIR NET Life Science Syllabus 2024 PDF here.

Chest radiograph deep-learning model for cardiac event risk estimation - Vimarsana News

Chest radiograph deep-learning model for cardiac event risk estimation

1. In this retrospective study, the chest X-ray cardiovascular disease (CXR CVD)-risk model performed similarly to the standard atherosclerotic (AS) CVD risk score at predicting 10-year risk for major adverse cardiovascular events (MACE). 2. Among patients with an unknown ASCVD risk score, those deemed statin-eligible by the model were nearly twice as likely to have

Opioid Prescriptions Nearly 3 Times More Likely in Patients with Rheumatic, Autoimmune Diseases - Vimarsana News

Opioid Prescriptions Nearly 3 Times More Likely in Patients with Rheumatic, Autoimmune Diseases

Patients with systemic autoimmune/inflammatory rheumatic diseases were nearly 3 times more likely to receive opioid prescriptions from 2006 to 2019.

Bariatric surgery may protect against development of breast cancer in women with obesity - Vimarsana News

Bariatric surgery may protect against development of breast cancer in women with obesity

Researchers investigated the association between bariatric surgery and breast cancer incidence in women and determined if baseline insulin levels influence the benefit of bariatric surgery on breast cancer risk.

Astrazeneca - New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease - Vimarsana News

Astrazeneca - New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease

Astrazeneca - New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease. The Phase IIa COURSE trial was a...